U.S. Renal Care Builds Its First Dialysis Center In Oklahoma

U.S. Renal Care, Inc. (USRC), a leading privately-held provider of outpatient dialysis services, today announced it has started construction of a dialysis center in Grove, Oklahoma, the company's first in the state. The center, expected to open in December 2010, will bring the company's patient total to more than 5,500 served across 85 dialysis centers, home and specialty hospital dialysis ...

Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Soaps, Lotions and Waterless Hand Rinses

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier Purchasing Partners, LP, today announced a new SEEDS™ agreement for soaps, lotions and waterless hand rinses has been awarded to Research Technologies Inc. of Greenville, S.C. Effective July 1, 2010, the agreements are available to acute care and continuum of care members of the Premier healthcare alliance. About the Premier healthcare alliance, 2006 ...

BARDA Funds Development Of New Way To Treat Illness From Acute Radiation

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) today awarded a $153 million contract to Cellerant Therapeutics, Inc. of San Carlos, Calif., to continue developing a new way to treat an illness caused by exposure to high levels of ionizing radiation which can damage the body's cells - the type of radiation that would come from a ...

InfraReDx Receives FDA Clearance For LipiScan™ IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the LipiScan™ IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound (IVUS) and near-infrared (NIR) spectroscopy ...

Sangart reports positive MP4OX Phase IIa study data in severely injured trauma patients with hemorrhagic shock

Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients.

InfraReDx receives 510(k) clearance to market LipiScan IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the LipiScan IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound and near-infrared spectroscopy to help ...

Humboldt County Court Proceedings Postponed One Additional Day

FOOTHILL RANCH, Calif., Sept. 1 /PRNewswire/ -- Skilled Healthcare Group, Inc. (NYSE: SKH) announced today that further court proceedings in the case entitled VINNIE LAVENDER, by and through her Conservator, WANDA BAKER; WALTER SIMON; JACQUELYN VILCHINSKY vs. SKILLED HEALTHCARE GROUP, INC., et al (and 22 individually-named California nursing facilities receiving administrative services from ...